Joseph A. Boystak


Joe is an experienced healthcare venture capitalist and senior healthcare investment banker having been Founding Managing Partner at Health2047 Capital Partners and Founding Managing Director, Global Life Sciences at Jefferies. He is CEO of Brightwaters Capital and is a serial co-founder/investor in biomedical, med tech, health information technology, and artificial intelligence companies with spinouts from UCLA, Johns Hopkins, Harvard/Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, among others.

Boystak is also named co-inventor on 5 issued US/EU patents for first-in-class medical technology developed by Bruin Biometrics LLC, a company he co-founded and was its initial Chairman. He has served on more than a dozen corporate and non-profit boards and currently serves on the Johns Hopkins Bloomberg School of Public Health and Southern California Biomedical Council (SoCalBio) Boards.

Boston University, BA, cum laude, Johns Hopkins, MHS, Wharton School, Executive Education

Marc Rapaport

Past Chairman

Marc Rapaport is the immediate past Chairman of the Board of Directors of Cedars-Sinai Medical Center (2016-2019), currently Chair of the Nominating Committee, and serves on, among others, the Executive Committee, Executive Personnel and Investment Committees. Marc has been active in the hospital’s Sports Spectacular since its inception in 1986 and a member of the Board of Governors for more than 25 years.

After practicing law in Los Angeles, he began his investment banking career at Drexel Burnham Lambert in 1983, where he served in a variety of positions including Executive Vice President and Co-Director of Domestic Capital Markets. In 1990, Marc co-founded the Capital Markets Division of Jefferies and Company, Inc., where he served as Executive Vice President.

He was also a director of the Board of Directors of Jefferies and Company, Inc. and a member of the firm’s Executive Committee until 1994.

Marc received his Juris Doctorate degree, cum laude, from Harvard Law School in 1981 and a Bachelor of Science, summa cum Claude, from the Wharton School of the University of Pennsylvania in 1978.

Vivek Garipalli

Board Member

Vivek Garipalli is a serial healthcare entrepreneur focused on innovating to increase quality healthcare access and improving patient outcomes. In 2008, Vivek Co-Founded CarePoint Health, a fully integrated healthcare system in New Jersey. Through his role at CarePoint – whose mission is to serve uninsured and underinsured patient populations. In 2012, Vivek launched the first ever national healthcare provider as Co-Founder and CEO & Board Member, Clover Health.

Vivek is active in health tech, serving as a Founding board member and investor of Flatiron Health. He began his career in finance, holding roles at Credit Suisse First Boston, J.P. Morgan Partners and Blackstone Group.

Vivek received a BA from Emory University with a concentration in entrepreneurship.

Ted Meisel

Board Member

Ted Meisel is an investor, entrepreneur and operator working to accelerate the change in our healthcare system towards patient-centered, value-based, clinician-friendly – and digital-first. He is executive founder of AVIA Health Innovation, a consulting firm to over fifty of the nation’s largest healthcare systems on technology-enabled transformation of the way they deliver and support care. He is Executive Chairman of WiserCare, which enables clinicians to help patients reach decisions faster, with greater precision, satisfaction and productivity. Ted is a Director of healthfinch, which automates routine clinical tasks performed by primary care clinicians. And he serves as a Director of Caravan Health, which serves 25k clinicians and 600k patients of the nation’s most effective accountable care organizations.

Ted received a BA from Dartmouth College and a Juris Doctorate from Stanford Law School.

Ananth Bhogaraju

Board Member

Ananth Bhogaraju was Vice Chairman of the Americas Healthcare Investment Banking Group at Deutsche Bank. He joined Deutsche Bank in 2005 as a Managing Director and Head of the Healthcare Services Investment Banking practice. Previously, Ananth worked at Credit Suisse First Boston where he was a Managing Director in the Healthcare Investment Banking Group. There he served on the firm’s North American Investment Banking Committee and the Global Business Development Council. Earlier in his career, he worked at Salomon Brothers in the Corporate Finance Group in New York focusing on the healthcare industry.

In 2015, Ananth founded Seven Hills Healthcare Advisors, a modern merchant bank focused on serving the global healthcare industry. Over the course of his 23-year investment banking career, Ananth has executed over 200 M&A and capital markets transactions in the United States, Europe, Latin America and Asia representing an aggregate transaction value in excess of $75 billion.

Ananth received a BA from Northwestern University where he earned a BA with dual majors in Economics and Political Science and The University of Chicago, Booth School of Business where he earned an MBA with dual concentrations in Finance and Accounting.

Larry Burstein

Board Member

Larry Burstein has been the Chairman and President of Unity Venture Capital Associates Ltd., since March 1996.

Mr. Burstein served a diverse group of organizations, including: President of Academic Computer Systems Inc.; President of Trinity Capital Corporation; President and Treasurer of Unity First Acquisition Corporation; Chairman of American Telecom Services Inc.; Director of Millennium India Acquisition Company Inc.; Director of CAS Medical Systems Inc.; Independent Director of ID Systems Inc.; Director of Uhf Incorporated; Director of Unity Venture Capital Associates Ltd., UCSI Inc., Brazil Fast Food Corp. and Trinity Capital Corporation; Director of Trinity Partners Acquistion Co. Inc.; Director of Medical Nutrition USA Inc.; Director of Academic Computer Systems Inc. and Unity First Acquisition Corporation, a publicly-held acquisition vehicle.

Mr. Burstein received a Bachelor of Arts in Economics from the Concordia University of Wisconsin and an L.L.B. from Columbia Law School.

Bob Battista, MBA, FRSPH, FRCP Edin.

Board Member

Bob cofounded DRE in 2004. Bob has worked extensively in the education and public health sectors. Bob has worked across the healthcare ecosystem from pharmaceutical/life science companies, medical device companies, providers, societies, academic institutions, policy groups and publishers among others. At DRE, he launched its GROWTH division and been responsible for all of the company’s product launches and associated go-to-market strategies. Prior to DRE, Bob has served as partner in charge of technology development as Executive Vice President of TheraCom, the first leading biotech pharmacy specializing in drug distribution, patient advocacy and reimbursement services.

In 2018 he was recognized with an honorary Surgeons’ designation into the Royal College of Physicians of Edinburgh.

Bob received a BA from National Lewis University, Chicago and an MBA from Northwestern University Kellogg Graduate School of Management.

Todd Feinman, MD

Board Member

Dr. Feinman cofounded DRE in 2004. A graduate of the David Geffen School of Medicine at the University of California (UCLA Medical School), Los Angeles, Dr. Feinman completed his internship at Cedars-Sinai Medical Center in Los Angeles, and his residency in Internal Medicine at Huntington Memorial Hospital in Pasadena, California. Dr. Feinman specialized in Hospitalist Medicine, and he helped develop the first Hospitalist programs at FHP Hospital, Queen of the Valley Hospital and Cedars-Sinai Medical Group.

At DRE, Dr. Feinman is responsible for all things related to the medical accuracy of the platform and product offerings.

Todd received a BS from UCLA and an MD from UCLA School of Medicine.